Vivek P. Chavda, Pankti C Balar, Srushti B. Patel, Diya J. Bhavsar, Margi V. Lakhani, Resa Parmar
{"title":"Antibody biopolymer conjugate","authors":"Vivek P. Chavda, Pankti C Balar, Srushti B. Patel, Diya J. Bhavsar, Margi V. Lakhani, Resa Parmar","doi":"10.1515/psr-2022-0193","DOIUrl":null,"url":null,"abstract":"Abstract Antibody treatment is an emerging field of treatment. They activate the immune system and help us fight foreign matter. Antibody biopolymer conjugates (ABC) is the futuristic preparation for successfully dealing with all the drawbacks of the unconjugated naked antibodies and improving the therapeutic effect. This chapter will state detailed information from the basics about its structure, its binding, and its mechanism of action. KSI-301 is one of the most researched and important molecules of ABC that is under many clinical trials. It helps to increase patient compliance by decreasing the frequent administration of a drug and hence improving the quality of life. The chapter also includes its current application and future aspects to fascinate the reader.","PeriodicalId":20156,"journal":{"name":"Physical Sciences Reviews","volume":"28 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Physical Sciences Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/psr-2022-0193","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Physics and Astronomy","Score":null,"Total":0}
引用次数: 0
Abstract
Abstract Antibody treatment is an emerging field of treatment. They activate the immune system and help us fight foreign matter. Antibody biopolymer conjugates (ABC) is the futuristic preparation for successfully dealing with all the drawbacks of the unconjugated naked antibodies and improving the therapeutic effect. This chapter will state detailed information from the basics about its structure, its binding, and its mechanism of action. KSI-301 is one of the most researched and important molecules of ABC that is under many clinical trials. It helps to increase patient compliance by decreasing the frequent administration of a drug and hence improving the quality of life. The chapter also includes its current application and future aspects to fascinate the reader.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
